Trikafta is expected to be a “game-changing” therapy for cystic fibrosis (CF), especially for younger patients, say researchers at Children’s Hospital of Richmond at Virginia Commonwealth University (VCU), who were involved in Trikafta trials where marked improvements were seen in patients taking the therapy. The medicine, developed by Vertex Pharmaceuticals, is a next-generation triple combination treatment […]
The post Trikafta Will Be ‘Life-Transforming,’ Especially for Younger CF Patients, Researchers Say appeared first on Cystic Fibrosis News Today. |
No hay comentarios:
Publicar un comentario